QIAGEN N.V. Cash and Cash Equivalents, Period Increase (Decrease)
QIAGEN N.V. (QGEN) reported Cash and Cash Equivalents, Period Increase (Decrease) of $501.37 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-03-06.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-03-06
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|
| 2018-12-31 | $501.37M 20-F · filed 2019-03-06 |
| 2017-12-31 | $218.53M 20-F · filed 2019-03-06 |
| 2016-12-31 | $149.17M 20-F · filed 2019-03-06 |
| 2015-12-31 | -$102.66M 20-F · filed 2018-03-06 |
| 2014-12-31 | $62.36M 20-F · filed 2017-03-06 |
| 2013-12-31 | -$63.73M 20-F · filed 2016-02-29 |
| 2012-12-31 | $172.90M 20-F · filed 2015-03-02 |
| 2011-12-31 | -$607.27M 20-F · filed 2014-03-03 |
| 2010-12-31 | $2.85M 20-F · filed 2013-03-04 |
| 2009-12-31 | $492.24M 20-F · filed 2012-03-27 |
| 2008-12-31 | -$14.01M 20-F · filed 2011-03-21 |